Patents by Inventor David W. Old

David W. Old has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7897629
    Abstract: Disclosed herein is a compound having a structure or a pharmaceutically acceptable salt thereof, or a prodrug thereof. Therapeutic methods, compositions, and medicaments related thereto are also disclosed.
    Type: Grant
    Filed: June 2, 2009
    Date of Patent: March 1, 2011
    Assignee: Allergan, Inc.
    Inventors: Robert M. Burk, David W. Old, Todd S. Gac
  • Patent number: 7879854
    Abstract: A compound comprising or a pharmaceutically acceptable salt thereof, or a prodrug thereof is disclosed herein. Y, A, and B are as described herein. Methods, compositions, and medicaments related to these compounds are also disclosed.
    Type: Grant
    Filed: April 22, 2009
    Date of Patent: February 1, 2011
    Assignee: Allergan, Inc.
    Inventors: David W. Old, Danny T. Dinh
  • Publication number: 20100317872
    Abstract: A compound having a substituted five or six-membered carbocycle or heterocycle directly bonded to a substituted aryl or heteroaryl ring, wherein said compound has an EC50 value of 20 nM or less at the prostaglandin EP2 receptor according to the cAMP assay. Methods, compositions, and medicaments related thereto are also disclosed.
    Type: Application
    Filed: August 20, 2010
    Publication date: December 16, 2010
    Applicant: ALLERGAN, INC.
    Inventors: Yariv Donde, Robert M. Burk, David W. Old
  • Publication number: 20100292293
    Abstract: Disclosed herein are compounds having a formula: (I) Compositions, methods, and medicaments related thereto are also disclosed.
    Type: Application
    Filed: October 16, 2008
    Publication date: November 18, 2010
    Inventors: David W Old, Vinh X. Ngo
  • Patent number: 7820661
    Abstract: Therapeutic compounds, compositions, medicaments, and methods are disclosed herein.
    Type: Grant
    Filed: April 22, 2009
    Date of Patent: October 26, 2010
    Assignee: Allergan, Inc.
    Inventors: David W. Old, Danny T. Dinh
  • Patent number: 7803798
    Abstract: Compounds comprising or a pharmaceutically acceptable salt or a prodrug thereof, are disclosed, wherein G, B, D, and Y are as described. Methods, compositions, and medicaments related thereto are also disclosed.
    Type: Grant
    Filed: April 22, 2009
    Date of Patent: September 28, 2010
    Assignee: Allergan, Inc.
    Inventors: David W. Old, Vinh X. Ngo
  • Patent number: 7803797
    Abstract: Compounds comprising or a pharmaceutically acceptable salt or a prodrug thereof, are disclosed, wherein G, B, Y, and A are as described. Methods, compositions, and medicaments related thereto are also disclosed.
    Type: Grant
    Filed: April 22, 2009
    Date of Patent: September 28, 2010
    Assignee: Allergan, Inc.
    Inventors: David W. Old, Vinh X. Ngo
  • Patent number: 7799821
    Abstract: A compound having a substituted five or six-membered carbocycle or heterocycle directly bonded to a substituted aryl or heteroaryl ring, wherein said compound has an EC50 value of 20 nM or less at the prostaglandin EP2 receptor according to the cAMP assay. Methods, compositions, and medicaments related thereto are also disclosed.
    Type: Grant
    Filed: May 30, 2006
    Date of Patent: September 21, 2010
    Assignee: Allergan, Inc.
    Inventors: Yariv Donde, Robert M. Burk, David W. Old
  • Patent number: 7795287
    Abstract: A compound having a structure is disclosed herein. Therapeutic methods, compositions, and medicaments related thereto are also disclosed.
    Type: Grant
    Filed: August 30, 2007
    Date of Patent: September 14, 2010
    Assignee: Allergan, Inc.
    Inventor: David W. Old
  • Patent number: 7786117
    Abstract: Compounds comprising or a pharmaceutically acceptable salt or a prodrug thereof, are disclosed, wherein J, B, Y, G and A are as described. Methods, compositions, and medicaments related thereto are also disclosed.
    Type: Grant
    Filed: May 6, 2009
    Date of Patent: August 31, 2010
    Assignee: Allergan, Inc.
    Inventor: David W. Old
  • Patent number: 7786154
    Abstract: A compound having the formula or a pharmaceutically acceptable salt or a prodrug thereof is disclosed herein. Y, A, and B are as described herein. Methods, compositions, and medicaments related to these compounds are also disclosed.
    Type: Grant
    Filed: May 22, 2009
    Date of Patent: August 31, 2010
    Assignee: Allergan, Inc.
    Inventor: David W. Old
  • Patent number: 7786150
    Abstract: Disclosed herein is a compound having a structure or a pharmaceutically acceptable salt, or a prodrug thereof. Therapeutic methods, compositions, and medicaments related thereto are also disclosed.
    Type: Grant
    Filed: May 14, 2009
    Date of Patent: August 31, 2010
    Inventors: David W. Old, Danny T. Dinh
  • Patent number: 7781482
    Abstract: A compound comprising or a pharmaceutically acceptable salt thereof, or a prodrug thereof is disclosed herein. Y, A, and B are as described herein. Methods, compositions, and medicaments related to these compounds are also disclosed.
    Type: Grant
    Filed: May 15, 2009
    Date of Patent: August 24, 2010
    Assignee: Allergan, Inc.
    Inventors: David W. Old, Danny T. Dinh
  • Patent number: 7781465
    Abstract: Disclosed herein is a compound represented by a formula Therapeutic methods, compositions, and medicaments related thereto are also disclosed.
    Type: Grant
    Filed: August 15, 2008
    Date of Patent: August 24, 2010
    Assignee: Allergan, Inc.
    Inventor: David W. Old
  • Publication number: 20100210689
    Abstract: Disclosed herein is a compound having a formula therapeutic methods, compositions, and medicaments related thereto are also disclosed.
    Type: Application
    Filed: January 22, 2010
    Publication date: August 19, 2010
    Applicant: ALLERGAN, INC.
    Inventors: David W. Old, Vinh X. Ngo
  • Patent number: 7772392
    Abstract: Compounds comprising or a pharmaceutically acceptable salt or a prodrug thereof; wherein a dashed line indicates the presence or absence of a bond; Y is an organic acid group, or an amide or ester thereof comprising from 1 to 12 carbon atoms; or Y is hydroxymethyl or an ether thereof comprising from 1 to 12 carbon atoms; or Y is a tetrazolyl group; A is —(CH2)6—, cis —CH2CH?CH—(CH2)3—, or —CH2C?C—(CH2)3—, wherein 1 or 2 carbon atoms may be substituted with S or O; or A is —(CH2)m—Ar—(CH2)o— wherein Ar is interarylene or heterointerarylene, the sum of m and o is from 1 to 4, and wherein one CH2 may be replaced with S or O; J is CHOH, C?O, CH2CHOH, or CH2C?O; and Ar1 is aryl, heteroaryl, CH2-aryl, CH2-heteroaryl, O-aryl, O-heteroaryl, S-aryl, or S-heteroaryl.
    Type: Grant
    Filed: March 17, 2006
    Date of Patent: August 10, 2010
    Assignee: Allergan, Inc.
    Inventors: David W. Old, Danny T. Dinh, Robert M. Burk
  • Publication number: 20100173981
    Abstract: Disclosed herein is a compound according to one of the formulas or a pharmaceutically acceptable salt thereof, medicaments for the treatment of glaucoma or ocular hypertension and compositions related thereto, as further elaborated herein.
    Type: Application
    Filed: January 30, 2008
    Publication date: July 8, 2010
    Applicant: Allergan, Inc.
    Inventors: Brent A. Johnson, David W. Old, Yariv Donde, Robert M. Burk
  • Publication number: 20100168189
    Abstract: Therapeutic compounds, compositions, methods, and medicaments related thereto are disclosed herein.
    Type: Application
    Filed: February 8, 2008
    Publication date: July 1, 2010
    Inventors: David W. Old, Wha Bin Im, Vinh X. Ngo
  • Publication number: 20100160407
    Abstract: Disclosed and described herein is a compound having a formula (I) therapeutic methods, medicaments, and compositions related thereto are also disclosed.
    Type: Application
    Filed: May 19, 2008
    Publication date: June 24, 2010
    Applicant: ALLERGAN, INC.
    Inventor: David W. Old
  • Patent number: 7737140
    Abstract: Compounds comprising or a pharmaceutically acceptable salt or a prodrug thereof, are disclosed, wherein J1, J2, U1, B, Y, and A are as described. Methods, compositions, and medicaments related thereto are also disclosed.
    Type: Grant
    Filed: April 21, 2009
    Date of Patent: June 15, 2010
    Assignee: Allergan, Inc.
    Inventors: David W. Old, Vinh X. Ngo